Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Concert Pharmaceuticals claims novel HIV protease inhibitors

Feb. 2, 2010

Ambrilia discloses HIV integrase inhibitors for the prevention and treatment of AIDS

Jan. 27, 2010

Cytheris initiates phase IIa INSPIRE 2 trial of CYT107 in HIV-infected patients

Jan. 18, 2010

Novel mixed-format HIV vaccine shows promise in phase I trial in healthy adult volunteers

Jan. 13, 2010

Gilead's Quad regimen meets primary objective in phase II trial in HIV-infected adults

Jan. 7, 2010

Dendritic cells do not enhance activity of canarypox-HIV vaccine

Jan. 7, 2010

Mylan receives tentative FDA approval for efavirenz tablets

Dec. 28, 2009

MRC reports results from international trial of PRO-2000 preventative HIV gel

Dec. 15, 2009

FDA grants traditional approval to Tibotec's NNRTI drug Intelence

Nov. 27, 2009

FDA grants GeoVax's request for pre-IND meeting on therapeutic AIDS vaccine

Nov. 24, 2009

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...